Relationship of UV exposure to prevalence of multiple sclerosis in England.
about
Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of SupplementationIs Multiple Sclerosis an Autoimmune Disease?Vitamin D as a clinical biomarker in multiple sclerosisFrequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.Environmental factors and multiple sclerosis severity: a descriptive study.Environmental effects of ozone depletion and its interactions with climate change: progress report, 2011Circulating microRNAs involved in multiple sclerosis.Month of birth, vitamin D and risk of immune-mediated disease: a case control studyGeographical variations in sex ratio trends over time in multiple sclerosis.Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosisMultiple sclerosis: is prevalence rising and if so why?Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisA population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trialThe Skin-Brain Connection Hypothesis, Bringing Together CCL27-Mediated T-Cell Activation in the Skin and Neural Cell Damage in the Adult Brain.Specific aspects of modern life for people with multiple sclerosis: considerations for the practitionerVitamin D in multiple sclerosis: implications for assessment and treatment.Glial influence on the blood brain barrier.The epidemiology of multiple sclerosis in the Isle of Man: 2006-2011.Vitamin D and multiple sclerosis—from epidemiology to prevention.Human skin pigmentation, migration and disease susceptibility.Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese population.Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial.Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.Vitamin D: a link between Epstein-Barr virus and multiple sclerosis development?Tripchlorolide ameliorates experimental autoimmune encephalomyelitis by down-regulating ERK1/2-NF-κB and JAK/STAT signaling pathways.Contribution of GPR30 for 1,25 dihydroxyvitamin D₃ protection in EAE.
P2860
Q27011804-8753847C-E920-47E9-B22A-263B1A9493C2Q27496011-16508104-AB05-4EA9-BDE1-FB738C2A7A9FQ28287015-56389BE9-B667-4FC6-801A-4B676B6C911AQ30459731-6568C65A-7EE5-468F-B2E2-696398015E73Q33834066-6F9E49AA-F3AA-4BFE-A5B7-7E9D526F63ABQ34141848-6F805D1F-223D-4899-B100-7E46FE5D983EQ34246016-0DAEA7F4-92B1-4720-A3CF-C2047FCCE697Q34327362-675BEEAE-7A67-4AD5-868D-71CA59F0C713Q34469310-63FC6A38-7DA2-4BC7-9AF8-B8F1E31BA2D2Q35231795-ACF1D7B6-0B18-4E24-B693-EEC5C72E0A76Q35651770-DD607924-1307-41E1-9BEE-F0F302EDAF1AQ36001269-B419ACC9-A267-4931-8D59-CE63EEFB1717Q36420302-92A943E0-A6C2-428B-8DED-1C9AAAF84F4FQ36638670-D4DD7E5D-08DA-4603-A7C1-07CA47622DA6Q37252462-4F14DFB6-32D3-48F0-BE99-49175C423FD0Q37351726-391393CD-63B1-48A1-B16F-7537EAD0A16FQ37587220-82DB6AA3-E24E-4A33-98E9-290B805E2E6DQ37599577-DF76E0A8-0C46-4FA7-AE2F-ED7CD0EFB16CQ38049627-6DAC2E6F-E4DD-4475-B73A-3F25C77B3A32Q38152380-6B1D09D6-9660-452C-91CE-B21CF7D175C7Q38428465-C10AB879-D2F2-4CB6-BCCD-74346BECF1DDQ38517185-1A5EA8BE-1DBC-478C-88CF-F6130568C56FQ39097638-E0EB9E98-A4D3-42B8-B2FF-C8AF0FD3CE4AQ41260520-CC1780CA-7BC6-4A7E-AF68-8AA6A8DB7472Q42246326-8070F354-AA28-431B-AAC5-0D0C1B7390BDQ42253738-396A0661-0AFB-4739-B566-EA523F8A1A6BQ42364107-A1356510-FB11-4A25-8AE4-A3FFBC23C12AQ44294582-537B8199-021D-4863-8BA6-C5C3F09B34F3Q45351891-BFAE9010-B223-4664-BE07-4095CF8275A7Q45363896-F04167D5-D362-441B-8A57-3B53D6D11E1EQ48338793-13769764-38A3-4094-9D46-F3DDAFD2F6B5Q48846709-A9878308-4AC6-4F06-855C-79D2AAAD6042
P2860
Relationship of UV exposure to prevalence of multiple sclerosis in England.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@ast
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@en
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@nl
type
label
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@ast
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@en
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@nl
prefLabel
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@ast
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@en
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@nl
P2093
P2860
P1433
P1476
Relationship of UV exposure to prevalence of multiple sclerosis in England.
@en
P2093
A E Handel
S Rutherford Siegel
S V Ramagopalan
P2860
P304
P356
10.1212/WNL.0B013E318216715E
P407
P577
2011-04-01T00:00:00Z